of in The Role of the in the A Molecular for Generating cAMP and cGMP Signaling Cross-Talk Role of Phosphodiesterases and Implications for Cardiac Pathophysiology
暂无分享,去创建一个
Manuela Zaccolo | M. Zaccolo | M. Movsesian | Matthew A Movsesian | Matthew A. Movsesian | Manuela Zaccolo | M. A. Movsesian
[1] E. Lakatta,et al. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. , 1999, Circulation research.
[2] E. Degerman,et al. Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[3] J. Scott,et al. Compartmentalisation of phosphodiesterases and protein kinase A: opposites attract , 2005, FEBS letters.
[4] A. Ketat,et al. Sildenafil citrate increases myocardial cGMP content in rat heart, decreases its hypertrophic response to isoproterenol and decreases myocardial leak of creatine kinase and troponin T , 2005, BMC pharmacology.
[5] H. C. Hartzell,et al. Rate-limiting steps in the beta-adrenergic stimulation of cardiac calcium current , 1993, The Journal of general physiology.
[6] L. Silengo,et al. PI3Kγ Modulates the Cardiac Response to Chronic Pressure Overload by Distinct Kinase-Dependent and -Independent Effects , 2004, Cell.
[7] Q. Yang,et al. A novel cyclic GMP stimulated phosphodiesterase from rat brain. , 1994, Biochemical and biophysical research communications.
[8] M. Zaccolo,et al. Compartmentalisation of cAMP and Ca(2+) signals. , 2002, Current opinion in cell biology.
[9] A. Shah,et al. Role of cyclic GMP‐dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes , 2002, The Journal of physiology.
[10] D. Kass,et al. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy , 2005, Nature Medicine.
[11] E. Degerman,et al. Cyclic Nucleotide Phosphodiesterases (PDEs): Diverse Regulators of Cyclic Nucleotide Signals and Inviting Molecular Targets for Novel Therapeutic Agents , 1999, Thrombosis and Haemostasis.
[12] J. Corbin,et al. Cyclic nucleotide phosphodiesterases: relating structure and function. , 2001, Progress in nucleic acid research and molecular biology.
[13] R. Ritchie,et al. Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP. , 2003, Cardiovascular research.
[14] E. Degerman,et al. Identification of a novel isoform of the cyclic-nucleotide phosphodiesterase PDE3A expressed in vascular smooth-muscle myocytes. , 2001, The Biochemical journal.
[15] R. Sharma,et al. Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1) , 1999, Cellular and Molecular Life Sciences CMLS.
[16] M. Zaccolo,et al. Restricted diffusion of a freely diffusible second messenger: mechanisms underlying compartmentalized cAMP signalling. , 2006, Biochemical Society transactions.
[17] D. Garbers,et al. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[18] V. Manganiello,et al. Isoforms of Cyclic Nucleotide Phosphodiesterase PDE3 and Their Contribution to cAMP Hydrolytic Activity in Subcellular Fractions of Human Myocardium* , 2005, Journal of Biological Chemistry.
[19] M. Mumby,et al. Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from bovine tissues. , 1982, The Journal of biological chemistry.
[20] D. Cooper,et al. Cyclic Guanosine Monophosphate Compartmentation in Rat Cardiac Myocytes , 2006, Circulation.
[21] M. Houslay,et al. Altered expression of PDE1 and PDE4 cyclic nucleotide phosphodiesterase isoforms in 7-oxo-prostacyclin-preconditioned rat heart. , 1997, Journal of molecular and cellular cardiology.
[22] E. Degerman,et al. Functions of the N-terminal Region of Cyclic Nucleotide Phosphodiesterase 3 (PDE 3) Isoforms* , 2000, The Journal of Biological Chemistry.
[23] K. Ferguson,et al. Isolation and characterization of human cDNAs encoding a cGMP-stimulated 3',5'-cyclic nucleotide phosphodiesterase. , 1997, Gene.
[24] L. Brunton,et al. Compartments of cyclic AMP and protein kinase in mammalian cardiomyocytes. , 1983, The Journal of biological chemistry.
[25] J. Balligand,et al. Nitric oxide synthase (NOS3)-mediated cholinergic modulation of Ca2+ current in adult rabbit atrioventricular nodal cells. , 1996, Circulation research.
[26] W. Sessa,et al. PKC&agr; Activates eNOS and Increases Arterial Blood Flow In Vivo , 2005 .
[27] E. Kranias,et al. Inotropic Responses to Isoproterenol and Phosphodiesterase Inhibitors in Intact Guinea Pig Hearts: Comparison of Cyclic AMP Levels and Phosphorylation of Sarcoplasmic Reticulum and Myofibrillar Proteins , 1989, Circulation research.
[28] A. Zeiher,et al. Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis. , 1998, Circulation research.
[29] Tullio Pozzan,et al. Discrete Microdomains with High Concentration of cAMP in Stimulated Rat Neonatal Cardiac Myocytes , 2002, Science.
[30] M. Zaccolo,et al. cGMP Catabolism by Phosphodiesterase 5A Regulates Cardiac Adrenergic Stimulation by NOS3-Dependent Mechanism , 2004, Circulation research.
[31] C. Hohl,et al. Compartmentation of cAMP in adult canine ventricular myocytes. Relation to single-cell free Ca2+ transients. , 1991, Circulation research.
[32] D. Cooper. Regulation and organization of adenylyl cyclases and cAMP. , 2003, The Biochemical journal.
[33] M. Conti. Phosphodiesterases and cyclic nucleotide signaling in endocrine cells. , 2000, Molecular endocrinology.
[34] P. Fisher,et al. Phosphodiesterase-5 Inhibition With Sildenafil Attenuates Cardiomyocyte Apoptosis and Left Ventricular Dysfunction in a Chronic Model of Doxorubicin Cardiotoxicity , 2005, Circulation.
[35] L. Langeberg,et al. mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module , 2001, The EMBO journal.
[36] B. Kobilka,et al. Phosphodiesterase 4D is required for beta2 adrenoceptor subtype-specific signaling in cardiac myocytes. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[37] R. Fischmeister,et al. cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes. , 1997, The Journal of clinical investigation.
[38] O. Brodde. Beta-adrenoceptors in cardiac disease. , 1993, Pharmacology & therapeutics.
[39] E. Degerman,et al. Regulation and function of the cyclic nucleotide phosphodiesterase (PDE3) gene family. , 2001, Progress in nucleic acid research and molecular biology.
[40] W. Sessa,et al. PKCalpha activates eNOS and increases arterial blood flow in vivo. , 2005, Circulation research.
[41] Anindita Das,et al. Protein kinase C plays an essential role in sildenafil-induced cardioprotection in rabbits. , 2004, American journal of physiology. Heart and circulatory physiology.
[42] J. Beavo,et al. Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use , 2006, Pharmacological Reviews.
[43] L. Langeberg,et al. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways , 2005, Nature.
[44] N. Klugbauer,et al. Another member of the cyclic nucleotide-gated channel family, expressed in testis, kidney, and heart. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[45] C. Deschepper,et al. Expression of Constitutively Active Guanylate Cyclase in Cardiomyocytes Inhibits the Hypertrophic Effects of Isoproterenol and Aortic Constriction on Mouse Hearts* , 2003, Journal of Biological Chemistry.
[46] J. Hell,et al. Localization of cardiac L-type Ca(2+) channels to a caveolar macromolecular signaling complex is required for beta(2)-adrenergic regulation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[47] P. Ferdinandy,et al. Effect of classic preconditioning on the gene expression pattern of rat hearts: a DNA microarray study , 2003, FEBS letters.
[48] J. Corbin,et al. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro. , 1999, The American journal of cardiology.
[49] W. Giles,et al. A cellular mechanism for nitric oxide-mediated cholinergic control of mammalian heart rate , 1995, The Journal of general physiology.
[50] M. Conti,et al. Short Term Feedback Regulation of cAMP in FRTL-5 Thyroid Cells , 2000, The Journal of Biological Chemistry.
[51] F. Salloum,et al. Sildenafil Induces Delayed Preconditioning Through Inducible Nitric Oxide Synthase–Dependent Pathway in Mouse Heart , 2003, Circulation research.
[52] M. Kuhn,et al. Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A. , 2003, Circulation research.
[53] K. Omori,et al. A Novel Interaction of cGMP-dependent Protein Kinase I with Troponin T* , 1999, The Journal of Biological Chemistry.
[54] J. Bos,et al. Epac proteins: multi-purpose cAMP targets. , 2006, Trends in biochemical sciences.
[55] G. Booz. Putting the brakes on cardiac hypertrophy: exploiting the NO-cGMP counter-regulatory system. , 2005, Hypertension.
[56] R. Kass,et al. Phosphorylation of the A-kinase-anchoring Protein Yotiao Contributes to Protein Kinase A Regulation of a Heart Potassium Channel* , 2005, Journal of Biological Chemistry.
[57] F. Hofmann,et al. The activation of expressed cGMP-dependent protein kinase isozymes I alpha and I beta is determined by the different amino-termini. , 1991, European journal of biochemistry.
[58] É. Rousseau,et al. Characterization of cyclic nucleotide phosphodiesterase isoforms associated to isolated cardiac nuclei. , 1999, Biochimica et biophysica acta.
[59] C. Lugnier. Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents. , 2006, Pharmacology & therapeutics.
[60] E. Fung,et al. Adrenomedullin Induces Direct (Endothelium-independent) Vasorelaxations and Cyclic Adenosine Monophosphate Elevations that Are Synergistically Enhanced by Brain Natriuretic Peptide in Isolated Rings of Rat Thoracic Aorta , 2003, Journal of cardiovascular pharmacology.
[61] C. Lugnier,et al. Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP: role in vasodilatation. , 1993, European heart journal.
[62] F. Hofmann,et al. cGMP-Dependent Protein Kinase I Mediates the Negative Inotropic Effect of cGMP in the Murine Myocardium , 2002, Circulation research.
[63] C. Dessauer,et al. Soluble Adenylyl Cyclase Reveals the Significance of cAMP Compartmentation on Pulmonary Microvascular Endothelial Cell Barrier , 2006, Circulation research.
[64] V. Coghlan,et al. Identification of cGMP-dependent protein kinase anchoring proteins (GKAPs). , 1998, Biochemical and Biophysical Research Communications - BBRC.
[65] J. Corbin,et al. Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylation. , 1998, The Biochemical journal.
[66] A. Shah,et al. Paracrine and autocrine effects of nitric oxide on myocardial function. , 2000, Pharmacology & therapeutics.
[67] G. Hindricks,et al. Polycystic disease of the kidneys complicating the diagnosis of myocardial echinococcosis. , 1993, European heart journal.
[68] J. Balligand,et al. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[69] D. Kass,et al. Cardiac phosphodiesterase 5 (cGMP‐specific) modulates β‐adrenergic signaling in vivo and is down‐regulated in heart failure , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[70] R. Fischmeister,et al. Cyclic GMP regulation of the L‐type Ca2+ channel current in human atrial myocytes , 2001, The Journal of physiology.
[71] R Fischmeister,et al. cAMP compartmentation is responsible for a local activation of cardiac Ca2+ channels by beta-adrenergic agonists. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[72] Xiaodong Cheng,et al. Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[73] P. Pattanaik,et al. Structural insights into the regulation and the activation mechanism of mammalian guanylyl cyclases. , 2004, Pharmacology & therapeutics.
[74] Roger Y. Tsien,et al. Insulin disrupts β-adrenergic signalling to protein kinase A in adipocytes , 2005, Nature.
[75] C. Trautwein,et al. Gene Transfer of cGMP-Dependent Protein Kinase I Enhances the Antihypertrophic Effects of Nitric Oxide in Cardiomyocytes , 2002, Hypertension.
[76] Suhn Hee Kim,et al. High and Low Gain Switches for Regulation of cAMP Efflux Concentration: Distinct Roles for Particulate GC- and Soluble GC-cGMP-PDE3 Signaling in Rabbit Atria , 2004, Circulation research.
[77] M. Conti,et al. Protein kinase B/Akt phosphorylation of PDE3A and its role in mammalian oocyte maturation , 2006, The EMBO journal.
[78] Nicola Elvassore,et al. PGE1 stimulation of HEK293 cells generates multiple contiguous domains with different [cAMP]: role of compartmentalized phosphodiesterases , 2006, The Journal of cell biology.
[79] F. Hofmann,et al. Regulation of cGMP-specific Phosphodiesterase (PDE5) Phosphorylation in Smooth Muscle Cells* , 2002, The Journal of Biological Chemistry.
[80] M. Zaugg,et al. Integration of calcium with the signaling network in cardiac myocytes. , 2006, Journal of molecular and cellular cardiology.
[81] Y. Shintani,et al. Potentiation of slow component of delayed rectifier K+ currentby cGMP via two distinct mechanisms: inhibition of phosphodiesterase 3 and activation of protein kinase G , 2002, British journal of pharmacology.
[82] U. Walter,et al. Increased effects of C‐type natriuretic peptide on contractility and calcium regulation in murine hearts overexpressing cyclic GMP‐dependent protein kinase I , 2003, British journal of pharmacology.
[83] J. Abe,et al. Role of Phosphodiesterase 3 in NO/cGMP-Mediated Antiinflammatory Effects in Vascular Smooth Muscle Cells , 2003, Circulation research.
[84] F. Fouque,et al. Activation of a cGMP-stimulated cAMP phosphodiesterase by protein kinase C in a liver Golgi-endosomal fraction. , 2001, European journal of biochemistry.
[85] J. Beavo,et al. The Calmodulin-dependent Phosphodiesterase Gene PDE1C Encodes Several Functionally Different Splice Variants in a Tissue-specific Manner* , 1996, The Journal of Biological Chemistry.
[86] M. Zaccolo,et al. Compartmentalized Phosphodiesterase-2 Activity Blunts &bgr;-Adrenergic Cardiac Inotropy via an NO/cGMP-Dependent Pathway , 2006, Circulation research.
[87] S. Jin,et al. Myomegalin Is a Novel Protein of the Golgi/Centrosome That Interacts with a Cyclic Nucleotide Phosphodiesterase* , 2001, The Journal of Biological Chemistry.
[88] Anindita Das,et al. Phosphodiesterase-5 Inhibitor Sildenafil Preconditions Adult Cardiac Myocytes against Necrosis and Apoptosis , 2005, Journal of Biological Chemistry.
[89] G. Livera,et al. Phosphodiesterase 4D Forms a cAMP Diffusion Barrier at the Apical Membrane of the Airway Epithelium* , 2005, Journal of Biological Chemistry.
[90] M. Lohse,et al. Cyclic AMP Imaging in Adult Cardiac Myocytes Reveals Far-Reaching &bgr;1-Adrenergic but Locally Confined &bgr;2-Adrenergic Receptor–Mediated Signaling , 2006, Circulation research.
[91] R Fischmeister,et al. Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. , 1993, The Journal of biological chemistry.
[92] J. Beavo,et al. Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[93] V. Ferrans,et al. Membrane Localization of Cyclic Nucleotide Phosphodiesterase 3 (PDE3) , 2000, The Journal of Biological Chemistry.
[94] M. Houslay,et al. In addition to the SH3 binding region, multiple regions within the N-terminal noncatalytic portion of the cAMP-specific phosphodiesterase, PDE4A5, contribute to its intracellular targeting. , 2002, Cellular signalling.
[95] V. Manganiello,et al. Molecular cloning of the rat adipocyte hormone-sensitive cyclic GMP-inhibited cyclic nucleotide phosphodiesterase. , 1993, The Journal of biological chemistry.
[96] K. Sadhu,et al. Isolation and Characterization of cDNAs Corresponding to Two Human Calcium, Calmodulin-regulated, 3′,5′-Cyclic Nucleotide Phosphodiesterases (*) , 1996, The Journal of Biological Chemistry.
[97] Roger Y Tsien,et al. Insulin disrupts beta-adrenergic signalling to protein kinase A in adipocytes. , 2005, Nature.
[98] J. Beavo,et al. Stimulation of adenosine 3',5'-monophosphate hydrolysis by guanosine 3',5'-monophosphate. , 1971, The Journal of biological chemistry.
[99] M. Houslay. A RSK(y) Relationship with Promiscuous PKA , 2006, Science's STKE.
[100] W. Sessa. eNOS at a glance , 2004, Journal of Cell Science.
[101] F. Hofmann,et al. The activation of expressed cGMP‐dependent protein kinase isozymes Iα and Iβ is determined by the different amino‐termini , 1991 .
[102] J. Beavo,et al. High concentrations of a cGMP-stimulated phosphodiesterase mediate ANP-induced decreases in cAMP and steroidogenesis in adrenal glomerulosa cells. , 1991, The Journal of biological chemistry.
[103] J. Schaack,et al. In Vivo Assessment of Local Phosphodiesterase Activity Using Tailored Cyclic Nucleotide–Gated Channels as Camp Sensors , 2001, The Journal of general physiology.
[104] M. Houslay,et al. Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T cell antigen receptor on thymocytes: analysis using the selective inhibitors erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) and rolipram. , 1996, Cellular signalling.
[105] Joao A. C. Lima,et al. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms , 2002, Nature.
[106] W. Hol,et al. GAF domains: two-billion-year-old molecular switches that bind cyclic nucleotides. , 2002, Molecular interventions.
[107] S. Reiken,et al. Phosphodiesterase 4D Deficiency in the Ryanodine-Receptor Complex Promotes Heart Failure and Arrhythmias , 2005, Cell.
[108] C. Roberts,et al. Atrial Natriuretic Peptide Induces Natriuretic Peptide Receptor-cGMP-dependent Protein Kinase Interaction* , 2003, Journal of Biological Chemistry.
[109] L. Brunton,et al. Cellular distribution of phosphodiesterase isoforms in rat cardiac tissue. , 1991, Circulation Research.
[110] M. Houslay,et al. PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. , 2003, The Biochemical journal.
[111] W. K. Sonnenburg,et al. Molecular cloning of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase cDNA. Identification and distribution of isozyme variants. , 1991, The Journal of biological chemistry.
[112] J. Knowles,et al. Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. , 2001, The Journal of clinical investigation.
[113] L. Brunton,et al. Functional compartmentation of cyclic AMP and protein kinase in heart. , 1981, Advances in cyclic nucleotide research.
[114] V Avdonin,et al. A beta2 adrenergic receptor signaling complex assembled with the Ca2+ channel Cav1.2. , 2001, Science.
[115] John D. Scott,et al. AKAP signalling complexes: focal points in space and time , 2004, Nature Reviews Molecular Cell Biology.
[116] M. Zaccolo,et al. Imaging Signal Transduction in Living Cells with GFP‐Based Probes , 2000, IUBMB life.
[117] Y. Furukawa,et al. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations. , 1998, The Journal of pharmacology and experimental therapeutics.
[118] V. Manganiello,et al. Isoforms of Cyclic Nucleotide Phosphodiesterase PDE3A in Cardiac Myocytes* , 2002, The Journal of Biological Chemistry.
[119] M. Silberbach,et al. Natriuretic Peptides and Nitric Oxide Stimulate cGMP Synthesis in Different Cellular Compartments , 2006, The Journal of general physiology.
[120] H. Drexler,et al. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[121] D. Cooper,et al. A Specific Pattern of Phosphodiesterases Controls the cAMP Signals Generated by Different Gs-Coupled Receptors in Adult Rat Ventricular Myocytes , 2006, Circulation research.
[122] S. Lohmann,et al. Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice. , 2002, Cardiovascular research.
[123] Martin J. Lohse,et al. Fluorescence Resonance Energy Transfer–Based Analysis of cAMP Dynamics in Live Neonatal Rat Cardiac Myocytes Reveals Distinct Functions of Compartmentalized Phosphodiesterases , 2004, Circulation research.
[124] Pierre L. Page,et al. Positive chronotropic and inotropic effects of C-type natriuretic peptide in dogs. , 1997, The American journal of physiology.